title: Will cetuximab-induced follicular rash get worse with moisturizers containing liquid paraffinum?
authors.affiliation: Department of Dermatology, University Hospital Spedali Civili, Brescia, Italy manganoni@spedalicivili.brescia.it.
authors.forename: Ausilia Maria
authors.initials: AM
authors.lastname: Manganoni
authors.affiliation: Department of Dermatology, University Hospital Spedali Civili, Brescia, Italy.
authors.forename: Laura
authors.initials: L
authors.lastname: Pavoni
authors.affiliation: Department of Dermatology, University Hospital Spedali Civili, Brescia, Italy.
authors.forename: Piergiacomo
authors.initials: P
authors.lastname: Calzavara-Pinton
mesh_terms: D017486:Acneiform Eruptions / Q000139:chemically induced* / Q000503:physiopathology; D000279:Administration, Cutaneous; D000328:Adult; D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002277:Carcinoma / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000188:drug therapy; D003875:Drug Eruptions / Q000209:etiology* / Q000503:physiopathology; D005076:Exanthema / Q000139:chemically induced* / Q000503:physiopathology; D005145:Face; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009959:Oropharyngeal Neoplasms / Q000188:drug therapy; D010232:Paraffin / Q000008:administration & dosage / Q000009:adverse effects*; D011537:Pruritus / Q000139:chemically induced; D060726:Torso
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D010232:Paraffin; D000068818:Cetuximab